Remedy Robotics raises $62 million to advance AI-powered cardiovascular surgery robot
Remedy Robotics, a San Francisco-based medical robotics company, has raised $62 million in Series B funding to advance its AI-enabled N1 System for cardiovascular and neurovascular procedures. The funding will support clinical trials, regulatory approval efforts and further development of the robotic platform, which is designed to enable endovascular procedures through on-site, remote and potentially […]
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
